NCT02314364
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Targetable Oncogenes (EGFR, ALK, ROS1)
Explore clinical trials studying Targetable Oncogenes (EGFR, ALK, ROS1). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies